13G Filing: Knoll Capital Management Files on Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Page 6 of 7 SEC Filing

Cusip
No.  
21833P103
13G Page
6 of 7 Pages

If filing as a non-U.S.
institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: _________________

Item 4. Ownership:

Provide the following information regarding
the aggregate number and percentage of class of securities of the issuer identified in Item 1.

(a) Amount beneficially owned:

As of this filing:

Gakasa beneficially
owns 2,563,925 Shares of the Issuer’s Common Stock.

Each of KCMLP and Knoll
beneficially own 2,563,925 Shares of the Issuer’s Common Stock. KCMLP has trading authority for Gakasa, and Knoll is the
President of KCMLP.

(b) Percent of Class:

The 2,563,925 shares of the Issuer’s Common Stock beneficially
owned by each of Gakasa, KCMLP and Knoll constitute 5.96 % of the Issuer’s Common Stock outstanding.

This percentage is calculated based on a total of 43,000,000
shares of the Company’s Common Stock outstanding as of January 7,2016 as reflected in Exhibit 99.1 of the company’s
January 7,2016 8K.

 

(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 2,563,925

KCMLP, Knoll
and Gakasa share the power to vote or direct the vote of those shares of Common Stock owned by Gakasa.

(iii) sole power to dispose or to direct the disposition of: 0
(iv) shared power to dispose or to direct the disposition of: 2,563,925

KCMLP, Knoll
and Gakasa share the power to dispose of or direct the disposition of those shares of Common Stock owned by Gakasa.

Item 5. Ownership of Five Percent or Less of a Class:

If this statement is
being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than
5 percent of the class of securities, check the following ¨.

Item 6. Ownership of More than Five Percent on Behalf of Another
Person:

Not Applicable.

Item 7. Identification and Classification of the Subsidiary
which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not Applicable.

Item 8. Identification and Classification of Members of the
Group:

Not Applicable.

Item 9. Notice of Dissolution of Group:

 

Not Applicable

Item 10. Certifications:

By Signing below I certify that, to the
best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.

 

Page 6 of 7

Follow Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)